Human papillomavirus (HPV) is the necessary cause of cervical cancer, the fourth most
common cancer and cause of cancer-related death in females worldwide. HPV also causes …

Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

The primary aim of the Swedish national population registration system is to obtain data that
(1) reflect the composition, relationship and identities of the Swedish population and (2) can …

Programmed death ligand 1 (PD L1) expression can reduce the immune response in both
infectious diseases and cancers. We thus examined PD L1 expression in cervical …

Background An increase in worldwide HPV vaccination could be facilitated if fewer than
three doses of vaccine are as effective as three doses. We originally aimed to compare the …

Importance Human papillomavirus (HPV) infections cause anogenital cancers and warts.
The 9-valent HPV vaccine provides protection against 7 high-risk types of HPV responsible …

Background Human papillomavirus (HPV) vaccines were first licensed as a three-dose
series. Two doses are now widely recommended in some age groups; there are data …

Since the discovery of the causal association between human papillomavirus (HPV) and
cervical cancer, efforts to develop an effective prophylactic vaccine to prevent high-risk HPV …

Background Human papillomavirus (HPV) vaccines were first licensed as a three-dose
series; a two-dose series is now recommended in some age groups and there is interest in …

Background Highly effective human papillomavirus (HPV) vaccines are used in many
national programs in 3-or 2-dose schedules. We examined HPV vaccine effectiveness …